Improving Healthcare Providers' Communication about HPV Vaccine

改善医疗保健提供者有关 HPV 疫苗的沟通

• 批准号: 8750208
• 负责人: Melissa B Gilkey
• 金额: $ 18.74万
• 依托单位: HARVARD PILGRIM HEALTH CARE, INC.
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-17 至 2017-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8750208
• 关键词: Address; Adolescent; Age; Area; Behavior; Behavior Therapy; Behavioral; Centers for Disease Control and Prevention (U.S.); Characteristics; Child; Clinic; Communication; Consensus; Data; Disease; Dose; Educational Intervention; Effectiveness; Family; Feasibility Studies; Federally Qualified Health Center; Female Adolescents; Frequencies; Goals; Guidelines; Health Personnel; Human Papilloma Virus Vaccination; Human Papilloma Virus Vaccine; Human Papillomavirus; Influentials; Intervention; K-Series Research Career Programs; Knowledge; Lead; Life; Literature; Low income; Male Adolescents; Malignant Neoplasms; Malignant neoplasm of cervix uteri; Medical; Medical Records; Melissa; Methods; Minority; Parents; Patients; Perception; Prevention program; Primary Health Care; Principal Investigator; Program Evaluation; Provider; Randomized Clinical Trials; Randomized Controlled Trials; Recommendation; Research; Research Personnel; Resources; Scientist; Self Efficacy; Surveys; Testing; Time; Training; Training Programs; Translating; Translational Research; Trust; United States; Vaccination; Vaccines; Visit; Woman; Work; base; boys; cancer prevention; career; clinical practice; cost; design; evidence base; improved; innovation; killings; multidisciplinary; prevent; programs; public health relevance; quality improvement organization; skills; social cognitive theory; uptake; vaccine delivery

PROJECT SUMMARY/ABSTRACT Despite national guidelines for routine administration of human papillomavirus (HPV) vaccine, only 33% of adolescent girls and 7% of adolescent boys in the U.S. currently receive all three recommended doses. Healthcare providers are highly influential in parents' decisions to get their adolescent children HPV vaccine, and yet providers often fail to recommend it. Further, recommendations providers do deliver are often weak. The overall goal of this study is to develop and evaluate a brief training program to improve providers' communication about HPV vaccine. This study will focus specifically on providers in Federally Qualified Health Centers because the low-income and minority adolescents served by these clinics are more likely to suffer from HPV-related cancers later in life. HPV vaccination is, thus, especially important in this setting. In terms of methods, we will first identify provider communication characteristics associated with HPV vaccine delivery (Aim 1). Using existing data, we will conduct a mixed-methods analysis of 204 audio-recorded medical encounters between providers, adolescent patients, and their parents. We will use findings from this analysis to develop a brief educational intervention for providers practicing in low-resource settings (Aim 2). Informed by social cognitive theory, the training's purpose will be to improve providers' knowledge, skills, and confidence for communicating about HPV vaccine. Finally, we will deliver the training to 16 providers in 4 Federally Qualified Health Centers to investigate the intervention's feasibility (Aim 3). Using audio-recordings of medical encounters and surveys of providers, patients, and parents, we will assess the intervention's ability to improve provider perceptions and recommendation practices as well as its acceptability to providers and families. The proposed study builds on Dr. Melissa Gilkey's prior work in survey research and program evaluation aimed at identifying and overcoming barriers to HPV vaccination. The candidate's long-term career goal is to translate research into evidence-based cancer prevention programs for adolescents. Her immediate career goals are to gain content knowledge in patient-provider communication, skills in developing behavioral interventions, and expertise in conducting randomized clinical trials to test those interventions. The proposed career development award will enable Dr. Gilkey to grow as an independent investigator by providing focused training as well as protected time for research. The proposed program of research will lay the groundwork for Dr. Gilkey's first R01-level study to establish the effectiveness of communication training for raising coverage of HPV vaccine.

项目总结/文摘